指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气

疑似或确诊COVID-19感染重症患者的强化支持治疗建议

Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
指南 / 共识 · Einstein (Sao Paulo) · 2020-06-03
一句话结论截至本文发布时,尚无针对确诊COVID-19感染的随机对照临床试验,本建议主要基于专家意见(推荐等级C级)。

本文为疑似或确诊COVID-19感染重症患者的强化支持治疗建议。文中指出,约20%的COVID-19确诊患者会发展为重症,包括急性低氧性呼吸衰竭、严重急性呼吸综合征、急性呼吸窘迫综合征和急性肾衰竭,需要入住重症监护病房。截至这些治疗建议发布时,尚无评估确诊COVID-19感染患者潜在治疗的随机对照临床试验,因此这些建议主要基于专家意见(推荐等级C级)。临床意义在于为重症患者的强化支持治疗提供基于专家共识的参考。

要点

  • 约20%的COVID-19确诊患者会发展为重症,包括急性低氧性呼吸衰竭、严重急性呼吸综合征、急性呼吸窘迫综合征和急性肾衰竭,需要入住重症监护病房。
  • 截至这些治疗建议发布时,尚无评估确诊COVID-19感染患者潜在治疗的随机对照临床试验。
  • 这些建议主要基于专家意见,推荐等级为C级。

适用人群与场景

  • 疑似或确诊COVID-19感染的重症患者。

研究设计与关键结果

  • 截至这些治疗建议发布时,尚无评估确诊COVID-19感染患者潜在治疗的随机对照临床试验;因此这些建议主要基于专家意见,推荐等级为C级。
  • 约20%的COVID-19确诊患者会发展为重症,包括急性低氧性呼吸衰竭、严重急性呼吸综合征、急性呼吸窘迫综合征和急性肾衰竭,需要入住重症监护病房。

证据类型、等级与局限

  • 证据类型:专家意见;推荐等级:C级。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 截至本文发布时,尚无针对确诊COVID-19感染患者的随机对照临床试验,因此这些建议主要基于专家意见(推荐等级C级)。

指南或共识出处

  • Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection(Einstein (Sao Paulo))。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).

Em dezembro de 2019, uma série de pacientes com pneumonia grave foi identificada em Wuhan, província de Hubei, na China. Esses pacientes evoluíram para síndrome respiratória aguda grave e síndrome do desconforto respiratório agudo. Posteriormente, a COVID-19 foi atribuída a um novo betacoronavírus, o coronavírus da síndrome respiratória aguda grave 2 (SARS-CoV-2). Cerca de 20% dos pacientes com diagnóstico de COVID-19 desenvolvem formas graves da doença, incluindo insuficiência respiratória aguda hipoxêmica, síndrome respiratória aguda grave, síndrome do desconforto respiratório agudo e insuficiência renal aguda e requerem admissão em unidade de terapia intensiva. Não há nenhum ensaio clínico randomizado controlado que avalie potenciais tratamentos para pacientes com infecção confirmada pela COVID-19 no momento da publicação destas recomendações de tratamento. Dessa forma, essas recomendações são baseadas predominantemente na opinião de especialistas (grau de recomendação de nível C).

来源:Einstein (Sao Paulo),查看原文。版权归原作者所有。

参考来源

  1. Corrêa TD, Matos GFJ, Bravim BA, et al. Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection. Einstein (Sao Paulo). 2020. PMID: 32520071. doi:10.31744/einstein_journal/2020AE5793

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。